We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ill. Jury Finds For AbbVie In AndroGel Bellwether Trial

Law360 (May 16, 2018, 7:50 PM EDT) -- An Illinois federal jury on Tuesday sided with AbbVie Inc. in the fifth bellwether trial in multidistrict litigation over its testosterone replacement therapy drug AndroGel, finding that the drug didn't cause an Arizona man to develop blood clots in his lungs.

After a trial that began on May 7, the jury found in favor of AbbVie on Arthur Myers and his wife Heathers’ claims that taking AndroGel caused him to suffer pulmonary emboli in February 2008. Like others in the MDL, the Myerses had claimed that AbbVie misleadingly marketed the drug as a safe and effective treatment for age-related lower testosterone....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!



Kirkland & Ellis LLP has redefined what it means to be the biggest of BigLaw — weighing in at 2,116 attorneys by year end 2018 and becoming the first firm since Law360 began tracking law firm head counts to top 2,000 U.S.-based attorneys.



Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Illinois Northern

Nature of Suit

367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability)


Subscribers Only

Date Filed

February 3, 2015

Law Firms


Government Agencies

Judge Analytics